BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 24565289)

  • 21. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.
    Hayden KM; Zandi PP; West NA; Tschanz JT; Norton MC; Corcoran C; Breitner JC; Welsh-Bohmer KA;
    Arch Neurol; 2009 Nov; 66(11):1378-83. PubMed ID: 19901170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E and mortality in African-Americans and Yoruba.
    Lane KA; Gao S; Hui SL; Murrell JR; Hall KS; Hendrie HC
    J Alzheimers Dis; 2003 Oct; 5(5):383-90. PubMed ID: 14646029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.
    Rajabli F; Feliciano BE; Celis K; Hamilton-Nelson KL; Whitehead PL; Adams LD; Bussies PL; Manrique CP; Rodriguez A; Rodriguez V; Starks T; Byfield GE; Sierra Lopez CB; McCauley JL; Acosta H; Chinea A; Kunkle BW; Reitz C; Farrer LA; Schellenberg GD; Vardarajan BN; Vance JM; Cuccaro ML; Martin ER; Haines JL; Byrd GS; Beecham GW; Pericak-Vance MA
    PLoS Genet; 2018 Dec; 14(12):e1007791. PubMed ID: 30517106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population.
    Stewart R; Russ C; Richards M; Brayne C; Lovestone S; Mann A
    Dement Geriatr Cogn Disord; 2001; 12(4):251-6. PubMed ID: 11351136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.
    Bretsky P; Guralnik JM; Launer L; Albert M; Seeman TE;
    Neurology; 2003 Apr; 60(7):1077-81. PubMed ID: 12682309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE ε4 status in healthy older African Americans is associated with deficits in pattern separation and hippocampal hyperactivation.
    Sinha N; Berg CN; Tustison NJ; Shaw A; Hill D; Yassa MA; Gluck MA
    Neurobiol Aging; 2018 Sep; 69():221-229. PubMed ID: 29909179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive Aging in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia.
    Weuve J; Barnes LL; Mendes de Leon CF; Rajan KB; Beck T; Aggarwal NT; Hebert LE; Bennett DA; Wilson RS; Evans DA
    Epidemiology; 2018 Jan; 29(1):151-159. PubMed ID: 28863046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of APOE ε4 Allele and Incident Stroke on Cognitive Decline and Mortality.
    Rajan KB; Aggarwal NT; Schneider JA; Wilson RS; Everson-Rose SA; Evans DA
    Alzheimer Dis Assoc Disord; 2016; 30(4):318-323. PubMed ID: 27849638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
    JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of
    GoodSmith MS; Wroblewski KE; Schumm LP; McClintock MK; Pinto JM
    Neurology; 2023 Sep; 101(13):e1341-e1350. PubMed ID: 37495381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOE genotype and cognitive decline in a middle-aged cohort.
    Blair CK; Folsom AR; Knopman DS; Bray MS; Mosley TH; Boerwinkle E;
    Neurology; 2005 Jan; 64(2):268-76. PubMed ID: 15668424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of African Ancestry-Specific APOE Missense Variant R145C With Risk of Alzheimer Disease.
    Le Guen Y; Raulin AC; Logue MW; Sherva R; Belloy ME; Eger SJ; Chen A; Kennedy G; Kuchenbecker L; O'Leary JP; Zhang R; Merritt VC; Panizzon MS; Hauger RL; Gaziano JM; Bu G; Thornton TA; Farrer LA; Napolioni V; He Z; Greicius MD
    JAMA; 2023 Feb; 329(7):551-560. PubMed ID: 36809323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.
    Liu X; Beck T; Dhana K; Tangney CC; Desai P; Krueger K; Evans DA; Rajan KB
    J Nutr Health Aging; 2024 May; 28(5):100211. PubMed ID: 38507884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOEε4 impacts up-regulation of brain-derived neurotrophic factor after a six-month stretch and aerobic exercise intervention in mild cognitively impaired elderly African Americans: A pilot study.
    Allard JS; Ntekim O; Johnson SP; Ngwa JS; Bond V; Pinder D; Gillum RF; Fungwe TV; Kwagyan J; Obisesan TO
    Exp Gerontol; 2017 Jan; 87(Pt A):129-136. PubMed ID: 27864047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults.
    Sawyer K; Sachs-Ericsson N; Preacher KJ; Blazer DG
    Gerontology; 2009; 55(1):32-40. PubMed ID: 18525196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.